500 patient records reviewed to understand Kidney-Liver syndrome outcomes
NCT ID NCT06095440
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study reviews medical records of 500 adults hospitalized with hepatorenal syndrome (HRS), a serious kidney problem linked to liver disease. Researchers aim to understand death rates, complications, and costs associated with HRS. No new treatments are given; the goal is to learn from past patient data to improve future care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATORENAL SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Liver Institute of Methodist Dallas Medical Center
RECRUITINGDallas, Texas, 75203, United States
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a common supplement help liver patients in intensive care?
- Could a lung drug save kidneys in liver patients?
- Which drug wins? trial pits terlipressin against octreotide for kidney crisis
- New algorithm aims to guide fluid treatment for kidney injury in cirrhosis patients
- Heart scans could help doctors treat kidney problems in liver disease patients
- New device hopes to help kidneys in liver patients